Research Topics
Species | Eleftherios DiamandisSummaryAffiliation: Mount Sinai Hospital Country: Canada Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluidsChristina V Obiezu
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Chem 51:1432-42. 2005..CONCLUSIONS: hK4 is found primarily in prostate tissue and is secreted in seminal plasma. Its value as a novel prostatic biomarker needs to be defined further...
Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brainsIlijana Begčević
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Clin Proteomics 10:5. 2013..High-throughput proteomic and pathway analysis of hippocampal tissue provides a valuable source of disease-related proteins and biomarker candidates, since it represents one of the earliest affected brain regions in AD...
Fascin-1 is a novel biomarker of aggressiveness in some carcinomasVathany Kulasingam
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
BMC Med 11:53. 2013..Please see related research article here http://www.biomedcentral.com/1741-7015/11/52...
Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndromeChan Kyung J Cho
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Clin Proteomics 10:2. 2013....
Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer TissueGeorge S Karagiannis
Mount Sinai Hospital, Joseph and Wolf Lebovic Center, 60 Murray St Box 32 Floor 6 Room L6 201, Toronto, ON M5T 3L9, Canada
Mol Cancer Res 10:1403-18. 2012..Not only does it provide essential signals for cancer cell dedifferentiation, proliferation, and survival but it also facilitates cancer cell local invasion and metastatic phenomena. Mol Cancer Res; 10(11); 1403-18. ©2012 AACR...
Revisiting the complexity of the ovarian cancer microenvironment--clinical implications for treatment strategiesNatasha Musrap
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Joseph and Wolf Lebovic Complex, Toronto, ON, Canada M5T 3L9
Mol Cancer Res 10:1254-64. 2012..Herein, an overview of the varying tumor-host interactions that influence tumor behavior will be discussed, in addition to the recent efforts undertaken to target these interactions and their potential to revolutionize EOC patient care...
The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?Eleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
BMC Med 10:87. 2012..I further provide examples of combinations of some known cancer biomarkers that can perform well in niche clinical applications, despite individually being not useful...
Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometryDaniel Kagedan
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
Clin Proteomics 9:2. 2012..abstract:..
Bioinformatic identification of proteins with tissue-specific expression for biomarker discoveryIoannis Prassas
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
BMC Med 10:39. 2012..Current biomarkers suffer from a lack of tissue specificity, rendering them vulnerable to non-disease-specific increases. The present study details a strategy to rapidly identify tissue-specific proteins using bioinformatics...
Cancer biomarkers: can we turn recent failures into success?Eleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 60 Murray St, Rm L6 201, Toronto, ON, Canada M5T 3L9
J Natl Cancer Inst 102:1462-7. 2010....
Human tissue kallikrein gene family: a rich source of novel disease biomarkersE P Diamandis
Dept of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
Expert Rev Mol Diagn 1:182-90. 2001..In this review, we examine the diagnostic and prognostic value of the 15 human kallikrein genes and proteins. It is clear that at least a few members show promise of becoming novel cancer and other disease biomarkers...
Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?Eleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5 Canada
Clin Chem 49:1272-5. 2003
Peptidomics for cancer diagnosis: present and futureEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
J Proteome Res 5:2079-82. 2006..Before this technology is used clinically, it is important to understand its advantages and limitations. These are summarized, along with proposals, on how to proceed in the future...
Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next stepsEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Cancer Res 66:5540-1. 2006
Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problemsEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
J Natl Cancer Inst 96:353-6. 2004
An update on human and mouse glandular kallikreinsEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
Clin Biochem 37:258-60. 2004..Here, we describe an update of the genomic organization of these families in human and mouse, and provide some thoughts for future research directions...
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patientsEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, M5G 1X5, Canada
Clin Biochem 37:823-9. 2004..Our preliminary studies indicate that hK11 may represent a diagnostic and prognostic biomarker for ovarian cancer. The aim of the present study was to examine the prognostic value of hK11 expression in ovarian tumors...
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementiaEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
Clin Biochem 37:230-7. 2004..Some of these enzymes can be measured in cerebrospinal fluid (CSF) by using ELISA-type methodologies...
Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitationsEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
Mol Cell Proteomics 3:367-78. 2004..It is clear that the method needs to be externally and thoroughly validated before clinical implementation is warranted...
Pentraxin-3 is a novel biomarker of lung carcinomaEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Clin Cancer Res 17:2395-9. 2011..Our objective was to validate the performance of three new candidate lung cancer biomarkers, pentraxin-3 (PTX3), human kallikrein 11 (KLK11), and progranulin...
Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networksIoannis Prassas
Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada
Mol Cancer Ther 10:2083-93. 2011..Hence, our findings provide more in-depth information regarding the molecular mechanisms underlying cardiac glycoside-induced cytotoxicity...
Human tissue kallikreins: a family of new cancer biomarkersEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Chem 48:1198-205. 2002..In addition to their diagnostic/prognostic potential, kallikreins may also emerge as attractive targets for therapeutics...
Duties and responsibilities of laboratory scientistsEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Chim Acta 319:111-5. 2002..The new developments in science and technology suggest that we are yet to realize the best times of this exciting profession...
Human kallikrein 11: a new biomarker of prostate and ovarian carcinomaEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
Cancer Res 62:295-300. 2002..This is the first reported immunological assay for hK11. Analysis of this biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma...
Human kallikrein 6 as a biomarker of alzheimer's diseaseE P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
Clin Biochem 33:663-7. 2000..Our aim was to examine the possible use of cerebrospinal fluid, blood and tissue, and human kallikrein 6 (hK6) concentration as a marker of AD...
Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applicationsE P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Clin Biochem 33:369-75. 2000..One new member is the KLK6 gene, encoding for human kallikrein 6 (hK6), which is also known as zyme/protease M/neurosin. In this paper, we describe development of antibodies and a sensitive immunofluorometric procedure for hK6 protein...
Prostate-specific antigen: a cancer fighter and a valuable messenger?E P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Chem 46:896-900. 2000..Despite the voluminous literature on this biomarker, relatively few reports have addressed the issue of its physiological function and its connection to the pathogenesis and progression of prostate and other cancers...
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinomaEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
J Clin Oncol 21:1035-43. 2003..The discovery of new ovarian cancer biomarkers that are suitable for early disease diagnosis and prognosis may ultimately lead to improved patient management and outcomes...
Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned mediumGirish Sardana
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Clin Chem 53:429-37. 2007..Additional tumor markers are needed for the early detection of clinically relevant CaP. Our objective was to perform a qualitative proteomic analysis of conditioned medium (CM) from the CaP cell line PC3(AR)(6)...
Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistryChristina V Obiezu
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, M5G 1X5 Canada
Clin Chem 48:1232-40. 2002..We propose that the protein either is not synthesized efficiently or is degraded very quickly...
Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluidsJulie L V Shaw
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada, M5G 1X5
Clin Biochem 40:104-10. 2007..The assay was then used to examine levels of KLK15 in tissues and biological fluids...
Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14Carla A Borgono
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
J Biol Chem 282:2405-22. 2007..These findings may have clinical implications for the management of cancer and other disorders in which KLK14 activity is elevated...
Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assayCarl Kapadia
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
Clin Chem 49:77-86. 2003..CONCLUSIONS: This immunofluorometric assay for hK13 may be used to examine the value of hK13 as a disease biomarker and to further explore the physiologic and pathobiologic role of this enzyme in human disease...
Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluidsTadaaki Kishi
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
Clin Chem 49:87-96. 2003..This assay can be used to explore the potential of hK8 as a marker of cancer or other conditions...
The kallikrein family of proteins as urinary biomarkers for the detection of prostate cancerGirish Sardana
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
Clin Biochem 42:1483-6. 2009..Here we examine the clinical utility of multiple members of the kallikrein family of proteins in non-manipulative urinary biomarker testing...
Emerging biomarkers for the diagnosis and prognosis of prostate cancerGirish Sardana
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Clin Chem 54:1951-60. 2008..Prostate-specific antigen (PSA) testing is a significant advance for early diagnosis of patients with CaP...
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinomaCarla A Borgono
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Int J Cancer 106:605-10. 2003..These results indicate that hK11 is a novel, independent marker of favorable prognosis in patients with ovarian cancer...
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancerGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Breast Cancer Res Treat 78:149-58. 2003..Similar results were obtained for overall survival. CONCLUSIONS: KLK9 is a new potential independent marker of favorable prognosis in breast cancer...
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancerGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
Cancer Res 63:3958-65. 2003..Our preliminary data indicate that hK5 is a potential biomarker in patients with ovarian and breast cancer...
Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkersGirish Sardana
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
J Proteome Res 7:3329-38. 2008....
Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasmaLiu-Ying Luo
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Cancer Res 12:742-50. 2006..We speculate that hK11, along with other kallikreins, proteases, and inhibitors, participates in a cascade enzymatic pathway responsible for semen liquefaction after ejaculation...
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosolsShannon J C Shan
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Clin Chem 52:1879-86. 2006..CONCLUSIONS: hK7 is associated with other unfavorable characteristics of ovarian cancer, but it is not an independent prognosticator for ovarian cancer...
Intron retention: a common splicing event within the human kallikrein gene familyIacovos P Michael
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada
Clin Chem 51:506-15. 2005..Some variants show tissue-specific expression. The KLK15 splice variant appears to be a candidate biomarker for prostate cancer...
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancerCarla A Borgono
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Ontario, Canada
Clin Cancer Res 12:1487-93. 2006..001 and P = 0.014, respectively). These results indicate that hK8 is an independent marker of favorable prognosis in ovarian cancer...
Prognostic value of the human kallikrein gene 15 expression in ovarian cancerGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
J Clin Oncol 21:3119-26. 2003..KLK15 is upregulated mainly by androgens and to a lesser extent by progestins. The purpose of this study was to examine the prognostic value of KLK15 in ovarian cancer tissues...
Human kallikrein 8, a novel biomarker for ovarian carcinomaTadaaki Kishi
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5, Canada
Cancer Res 63:2771-4. 2003..These data suggest that hK8 protein is detectable in ovarian cancer tissue extracts, serum, and ascites fluid, indicating that it may serve as a new ovarian cancer marker...
Human kallikrein 14: a new potential biomarker for ovarian and breast cancerCarla A Borgono
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Cancer Res 63:9032-41. 2003..Our preliminary data indicate that hK14 is a potential biomarker for breast and ovarian cancers...
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissuesGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
Prostate 56:287-92. 2003..Since KLK14 was found to be regulated by steroid hormones in prostate cancer cell lines, we hypothesized that it will be differentially expressed in prostate cancer tissues compared to their normal counterparts...
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosisLiu-Ying Luo
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
Cancer Res 63:807-11. 2003..Serum hK10 represents a novel biomarker for ovarian cancer. We conclude that preoperative serum hK10 concentration is a strong and independent unfavorable prognostic marker for ovarian cancer...
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancerGeorge M Yousef
Dept of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
Am J Clin Pathol 119:346-55. 2003..43 and 0.53; P = .027 and .014). A weak negative correlation was found between KLK14 expression and serum CA-125. KLK14 is a new, independent, and favorable prognostic marker for ovarian cancer...
Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancerC Geeth Gunawardana
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
J Proteome Res 8:4705-13. 2009..We conclude that in-depth proteomic analysis of cell culture supernatants of ovarian cancer cell lines can identify potential ovarian cancer biomarkers that are worth further clinical validation...
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancersBhupinder B Bharaj
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Prostate 51:35-41. 2002..KLK10 is also upregulated in ovarian cancer. We thus hypothesized that the KLK10 gene may be a target for mutations in various cancers...
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
Prostate 51:126-32. 2002..4. Like KLK2 and KLK3, the KLK5 gene is regulated by steroid hormones in the BT-474 breast cancer cell line. We have previously shown that KLK5 is differentially expressed in ovarian and breast cancer...
Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkersCynthia Kuk
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G 1L5, Canada
Mol Cell Proteomics 8:661-9. 2009..Our proteomics approach for discovering novel ovarian cancer biomarkers appears to be highly efficient because it was able to identify 25 known biomarkers and 52 new candidate biomarkers that warrant further validation...
Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptorMiltiadis Paliouras
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Mol Oncol 1:413-24. 2008..The synergistic effects between estrogens and androgens on estrogen-sensitive genes may have implications on the role of the kallikreins in associated risk of breast cancer and progression...
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expressionMiltiadis Paliouras
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont, Canada
Tumour Biol 29:63-75. 2008..Our aim was to examine how certain signal transduction pathways influence the regulation of hormone-dependent kallikrein (KLK) gene expression in androgen-sensitive breast cancer cell lines...
Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot studyKaterina Oikonomopoulou
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
Tumour Biol 27:104-14. 2006..Kallikrein expression may have some value for differentiating ovarian cancer from other types of cancer or from non-malignant diseases that lead to ascites accumulation...
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissuesTerukazu Nakamura
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Urology 61:1042-6. 2003..4. Hippostasin has two alternative splicing isoforms, known as the brain type and prostate type. We have previously reported that the prostate-type isoform is not expressed in human prostate cancer cell lines...
Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancerLisa Kurlender
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
Tumour Biol 25:149-56. 2004..KLK5-SV1 may have clinical utility in various malignancies and should be further explored as a potential new biomarker for prostate and ovarian cancer...
Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluidsTadaaki Kishi
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Chem 50:709-16. 2004..CONCLUSIONS: This study describes the first ELISA-type immunoassay for hK7 protein quantification. hK7 is found many human tissues and in various biological fluids...
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patientsMaryam Zarghooni
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Clin Biochem 35:225-31. 2002..Our objective was to develop a highly sensitive immunoassay for hK6 and use it to examine the levels of hK6 in brain tissue extracts from Alzheimer's disease patients and control subjects...
Collecting duct carcinoma associated with oncocytomaGeorge M Yousef
Memorial University, St John s, Canada
Int Braz J Urol 31:465-7; discussion 467-9. 2005..Identification and reporting CDC is important for the establishment of treatment strategies and monitoring prognosis...
Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAsNicole M White
Department of Laboratory Medicine and the Keenan Research Center in the Li Ka Shing Knowledge Institute, St Michael s Hospital, Toronto, Ontario, Canada
Biol Chem 391:411-23. 2010..The observation that KLKs could represent targets for miRNAs suggests a post-transcriptional regulatory mechanism with possible future therapeutic applications...
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosisEleftherios P Diamandis
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
Tumour Biol 24:299-309. 2003..297; p < 0.001). Our findings provide evidence for an association between hK5 and more aggressive forms of epithelial ovarian cancer...
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancerLianna G Kyriakopoulou
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 1X5 Canada
Clin Biochem 36:135-43. 2003..6). CONCLUSIONS: We conclude that higher KLK7 expression in ovarian cancer tissue is associated with poorer prognosis of ovarian cancer patients, especially those with lower grade disease and those who have been optimally debulked...
Mass spectrometry: uncovering the cancer proteome for diagnosticsDa elene van der Merwe
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G1X5, Canada
Adv Cancer Res 96:23-50. 2007..It is essential that research groups, the industry, and physicians collaborate to conduct large prospective, multicenter clinical trials to validate and standardize this technology, for it to have real clinical impact...
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detectionRobert K Nam
Division of Urology, 2075 Bayview Ave, MG 406, Toronto, Ontario, Canada, M4N 3M5
J Clin Oncol 21:2312-9. 2003..We examined the relationship between a mutant (T) for wild-type (C) allele substitution of the human kallikrein-2 gene (KLK2), circulating human kallikrein-2 (hK2) levels and prostate cancer risk...
Complex formation between human kallikrein 13 and serum protease inhibitorsCarl Kapadia
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
Clin Chim Acta 339:157-67. 2004..Given that other kallikreins are sequestered by serum protease inhibitors, we hypothesized that hK13 may also interact with similar inhibitors. Our objective was to identify serum protease inhibitors that interact with human hK13...
Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motilityNashmil Emami
Department of Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada
Biol Chem 390:921-9. 2009..In conclusion, the expression level of several seminal plasma KLKs correlates with liquefaction and viscosity indicators of semen quality and may aid in their differential diagnosis and etiology...
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell linesChris Planque
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G1X5, Canada
Mol Cell Proteomics 8:2746-58. 2009..Our results demonstrate the utility of this cell culture proteomics approach to identify secreted and shed proteins that are potentially useful as serological markers for lung cancer...
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancersMichael Sidiropoulos
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
Tumour Biol 26:324-36. 2005..Recently, it has been shown that CpG island hypermethylation of the KLK10 gene is responsible for the tumor-specific loss of KLK10 gene expression in certain breast cancer cell lines...
Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissuesNader Memari
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Prostate 67:1465-74. 2007..Here, we report generation of antibodies against the full-length recombinant KLK12 (classical form) and the immunohistological localization of this KLK in normal and malignant prostate tissues...
High throughput proteomic strategies for identifying tumour-associated antigensC Geeth Gunawardana
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont, Canada
Cancer Lett 249:110-9. 2007..In this mini-review, we aim to describe these three techniques and provide their advantages and disadvantages. In addition, we aim to address some of the challenges of cancer immunomics...
Tissue kallikreins: new players in normal and abnormal cell growth?George M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Thromb Haemost 90:7-16. 2003..For example, hK6, 10 and 11 are promising serological markers for ovarian cancer diagnosis. KLK10 may act as a tumor suppressor. In addition to their diagnostic and prognostic values, kallikreins may also be good therapeutic targets...
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasiaTerukazu Nakamura
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada
Cancer Res 63:6543-6. 2003..69). These preliminary data suggest that the hK11:total PSA ratio could be a useful tumor marker for CaP and could be combined with percentage of PSA to further reduce the number of unnecessary prostatic biopsies...
Human tissue kallikreins: from gene structure to function and clinical applicationsGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
Adv Clin Chem 39:11-79. 2005
Human tissue kallikrein gene family: applications in cancerChristina V Obiezu
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ont, Canada M5G 1X5
Cancer Lett 224:1-22. 2005..We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management...
Re: Serum proteomic patterns for detection of prostate cancerEleftherios P Diamandis
J Natl Cancer Inst 95:489-90; author reply 490-1. 2003
Potential markers that complement expression of CA125 in epithelial ovarian cancerDaniel G Rosen
Department of Pathology, University of Texas M.D. Anderson Cancer Center, Box 355, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Gynecol Oncol 99:267-77. 2005..Several markers exhibited more intense expression in cancers than in normal organs. Further investigation is needed to demonstrate complementary expression of markers in serum...
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSAAndreas Scorilas
National Center for Scientific Research Demokritos, IPC, Athens, Greece
Prostate 54:220-9. 2003..CONCLUSIONS: hK2/free PSA and IGF-1/free PSA ratios may be useful adjuncts in improving patient selection for prostate biopsy...
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic markerAndreas Scorilas
Department of Biochemistry and Molecular Biology, University of Athens, Greece
J Clin Oncol 22:678-85. 2004..007 and P =.002, respectively). CONCLUSION: These results indicate that hK13 is an independent marker of favorable prognosis in ovarian cancer...
Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancerEdward R Sauter
Department of Surgery, University of Missouri Columbia, M588 Health Sciences Center, One Hospital Drive, Columbia, MO 65212, USA
Cancer Detect Prev 28:27-31. 2004..009), nodal status (P = 0.005), disease stage (P = 0.004), and distant metastases (P = 0.04). NAF PSA provides useful prognostic information which may assist with breast cancer treatment...
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancerCarsten Stephan
Department of Urology, University Hospital Charit, Humboldt University Berlin, Berlin, Germany
Urology 59:2-8. 2002
Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detectionCarsten Stephan
Department of Urology, Univeristy Hospital Charité, Berlin, Germany
BJU Int 96:521-7. 2005....
Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsinShirley Hutchinson
Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, M5G 1X5 Canada
Clin Chem 49:746-51. 2003..Human kallikrein 6 (hK6) is significantly increased in serum in many patients with ovarian cancer and may have a role in amyloid precursor processing and Alzheimer disease. The forms of hK6 in biological fluids are poorly characterized...
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapyYingye Zheng
The Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Clin Cancer Res 13:6984-92. 2007....
An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markersGeorge M Yousef
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Biochem 36:443-52. 2003..Of special interest is the potential role of kallikreins in the central nervous system. In addition, many kallikreins seem to be candidate tumor markers for many malignancies, especially those of endocrine-related organs...
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinomaMaroulio Talieri
G Papanicolaou Research Center of Oncology, Saint Savas Hospital, Athens Greece
Thromb Haemost 91:180-6. 2004..These data suggest that KLK7 gene expression may be used as a marker of unfavorable prognosis for breast cancer patients...
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancerCarsten Stephan
Department of Urology, University Hospital Charite Berlin, Berlin, Germany
Int J Urol 13:238-43. 2006..We investigated the role of hK2 serum values for predicting pathological stage, grade and Gleason score...
Association of kallikrein expression in nipple aspirate fluid with breast cancer riskEdward R Sauter
Department of Surgery, University of Missouri, Columbia, MO 65212, USA
Int J Cancer 108:588-91. 2004..hK2 and PSA, and hK6 and hK10 are highly associated. Higher premenopausal PSA levels suggest the influence of ovarian steroids. PSA shows the most promise in aiding in the early detection of breast cancer...
Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural networkCarsten Stephan
Department of Urology, University Hospital Charite Berlin, Berlin, Germany
Prostate 66:651-9. 2006....
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinomaConstantina D Petraki
Department of Pathology, Evangelismos Hospital, Athens, Greece
Tumour Biol 27:1-7. 2006....
Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinomaMartin W McIntosh
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Clin Cancer Res 13:4422-8. 2007..The human kallikrein 11 (hK11) marker has been reported to have favorable predictive value for ovarian cancer, although, by itself, it may be inferior to CA 125...
POINT: EPCA-2: a promising new serum biomarker for prostatic carcinoma?Eleftherios P Diamandis
Clin Biochem 40:1437-9. 2007
Research Grants
- Human Kallikrein 4 (hK4): A New Prostatic Biomarker?Eleftherios Diamandis; Fiscal Year: 2003..If successful, our research will contribute to the development of new prostatic biomarkers and possibly, to better diagnosis which may lead to better clinical outcomes and reduced healthcare costs. ..
- A New Biomarker for Ovarian Cancer DetectionEleftherios Diamandis; Fiscal Year: 2003..In this grant proposal, we describe further studies, which will examine in greater detail, the ability of a test for the amount of this protein in blood to correctly diagnose the presence of ovarian cancer. ..
- KALLIKREINS AS DIAGNOSTIC MARKERS OF OVARIAN CARCINOMAEleftherios Diamandis; Fiscal Year: 2007..Relevance of this research to public health: By achieving early ovarian cancer diagnosis, it will be possible to reduce the burden of the disease by administration of effective treatment as early as possible. ..
